Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2025)
Janux Therapeutics (JANX) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.01 as the latest value for Q4 2025.
- On a quarterly basis, Asset Utilization Ratio fell 18.13% to 0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01, a 18.13% decrease, with the full-year FY2025 number at 0.01, down 33.99% from a year prior.
- Asset Utilization Ratio was 0.01 for Q4 2025 at Janux Therapeutics, up from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.03 in Q1 2023 to a low of 0.0 in Q2 2025.
- A 5-year average of 0.02 and a median of 0.02 in 2024 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: surged 278.17% in 2022, then crashed 98.08% in 2025.
- Janux Therapeutics' Asset Utilization Ratio stood at 0.01 in 2021, then surged by 146.76% to 0.02 in 2022, then dropped by 9.51% to 0.02 in 2023, then crashed by 42.78% to 0.01 in 2024, then dropped by 18.13% to 0.01 in 2025.
- Per Business Quant, the three most recent readings for JANX's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.0 (Q2 2025).